Adding Mycophenolate Mofetil Improves Outcomes in ITP

(MedPage Today) -- The addition of mycophenolate mofetil (MMF) to a glucocorticoid as a first-line treatment for immune thrombocytopenia (ITP) resulted in greater responses and a reduced risk of relapse or refractory disease, according to the results...